ZA923607B - Vaccines and methods for their production - Google Patents

Vaccines and methods for their production

Info

Publication number: ZA923607B
Authority: ZA; South Africa
Prior art keywords: virus; vaccines; production; methods; treating
Prior art date: 1991-05-17

Application number

ZA923607A

Other languages

English (en)

Inventor

John Sidney Oxford

Sidney Oxford John

Original Assignee

Retroscreen Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-17

Filing date

1992-05-18

Publication date

1993-02-24

1992-05-18 Application filed by Retroscreen Ltd filed Critical Retroscreen Ltd

1993-02-24 Publication of ZA923607B publication Critical patent/ZA923607B/xx

Links

238000004519 manufacturing process Methods 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title abstract 2
241000700605 Viruses Species 0.000 abstract 4
239000003795 chemical substances by application Substances 0.000 abstract 2
230000000415 inactivating effect Effects 0.000 abstract 2
229940124718 AIDS vaccine Drugs 0.000 abstract 1
239000003431 cross linking reagent Substances 0.000 abstract 1
239000003599 detergent Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
230000003019 stabilising effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
- C12N2760/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Telephone Function (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

ZA923607A 1991-05-17 1992-05-18 Vaccines and methods for their production ZA923607B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919110808A GB9110808D0 (en)	1991-05-17	1991-05-17	Aids vaccine and method for its production

Publications (1)

Publication Number	Publication Date
ZA923607B true ZA923607B (en)	1993-02-24

Family

ID=10695252

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA923607A ZA923607B (en)	1991-05-17	1992-05-18	Vaccines and methods for their production

Country Status (16)

Country	Link
US (1)	US5698432A (pt)
EP (1)	EP0514199B1 (pt)
JP (1)	JPH05328967A (pt)
KR (1)	KR0149182B1 (pt)
AT (1)	ATE172642T1 (pt)
AU (1)	AU652447B2 (pt)
BR (1)	BR9201848A (pt)
CA (1)	CA2068817A1 (pt)
DE (1)	DE69227400T2 (pt)
ES (1)	ES2127203T3 (pt)
GB (1)	GB9110808D0 (pt)
IE (1)	IE921556A1 (pt)
IN (1)	IN174080B (pt)
NZ (1)	NZ242780A (pt)
SG (1)	SG49763A1 (pt)
ZA (1)	ZA923607B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69131427T2 (de) *	1991-05-28	1999-11-25	Kabushiki Kaisha Toshiba, Kawasaki	Arbeitsvorrichtung
AUPN030794A0 (en)	1994-12-22	1995-01-27	Aruba International Pty Ltd	Discontinuous plasma or serum delipidation
DE19520216C2 (de) *	1995-06-01	1997-04-10	Frey Rainer H	Vakzine zur Prophylaxe und Therapie von AIDS, und Verfahren zur Herstellung
US20040053208A1 (en) *	1995-08-29	2004-03-18	V. I. TECHNOLOGIES, Inc.	Methods to selectively inactivate parasites in biological compositions
US6352695B1 (en)	1997-10-03	2002-03-05	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US6093564A (en) *	1997-10-03	2000-07-25	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US6617100B2 (en)	1998-09-25	2003-09-09	V.I. Technologies, Inc.	Solid phase quenching systems
US6403359B1 (en)	1998-09-25	2002-06-11	V. I. TECHNOLOGIES, Inc.	Solid phase quenching systems
DE19916085A1 (de) *	1998-10-28	2000-05-04	Sonntag Hans Guenther	Verfahren zur Herstellung eines antiviralen Mittels
US6649170B1 (en) *	1999-05-12	2003-11-18	Statens Serum Institut	Adjuvant combinations for immunization composition and vaccines
TR200202104T2 (tr) *	1999-12-20	2002-12-23	Agricultural Research Council	Mikroorganizmaların etkisiz hale getirilmesi yöntemi.
US20090017069A1 (en)	2000-06-29	2009-01-15	Lipid Sciences, Inc.	SARS Vaccine Compositions and Methods of Making and Using Them
US7439052B2 (en)	2000-06-29	2008-10-21	Lipid Sciences	Method of making modified immunodeficiency virus particles
US7407662B2 (en) *	2000-06-29	2008-08-05	Lipid Sciences, Inc.	Modified viral particles with immunogenic properties and reduced lipid content
US7407663B2 (en) *	2000-06-29	2008-08-05	Lipid Sciences, Inc.	Modified immunodeficiency virus particles
AUPQ846900A0 (en) *	2000-06-29	2000-07-27	Aruba International Pty Ltd	A vaccine
US6991727B2 (en)	2001-06-25	2006-01-31	Lipid Sciences, Inc.	Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en)	2001-06-25	2006-03-23	Bomberger David C	Systems and methods using a solvent for the removal of lipids from fluids
US7033500B2 (en) *	2001-06-25	2006-04-25	Lipid Sciences, Inc.	Systems and methods using multiple solvents for the removal of lipids from fluids
DE10144906B4 (de) *	2001-09-12	2013-11-28	Novartis Vaccines And Diagnostics Gmbh	Verfahren zur großtechnischen Herstellung von Impfstoffen
WO2003048366A1 (en) *	2001-12-07	2003-06-12	Postech Foundation	Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
EP2368565B1 (en)	2003-07-03	2015-06-24	HDL Therapeutics, Inc.	Enrichment of pre-beta high density lipoproteins
US7393826B2 (en)	2003-07-03	2008-07-01	Lipid Sciences, Inc.	Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
EP2192917B1 (en) *	2007-08-28	2014-01-29	Baxter International Inc.	Method for producing viral vaccines
CN102858961A (zh)	2010-05-03	2013-01-02	葛兰素史密丝克莱恩生物有限公司	新方法
CN104350066B (zh)	2012-06-01	2018-06-19	勃林格殷格翰动物保健有限公司	施马伦贝格病毒(sbv)疫苗、其制备方法及用途
IN2014MN02492A (pt)	2012-06-08	2015-07-17	Aduro Biotech
AU2013358892B2 (en)	2012-12-13	2018-06-21	Aduro Biotech, Inc.	Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
PE20160167A1 (es)	2013-04-29	2016-04-21	Sloan Kettering Inst Cancer	Composiciones y metodos para alterar la senalizacion del segundo mensajero
EP2992000B1 (en)	2013-05-03	2020-07-08	The Regents of The University of California	Cyclic di-nucleotide induction of type i interferon
CN105228450B (zh)	2013-05-18	2019-01-18	艾杜罗生物科技公司	用于活化“干扰素基因刺激因子”-依赖性信号传导的组合物和方法
US9549944B2 (en)	2013-05-18	2017-01-24	Aduro Biotech, Inc.	Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
US10176292B2 (en)	2013-07-31	2019-01-08	Memorial Sloan-Kettering Cancer Center	STING crystals and modulators
JP5865942B2 (ja)	2014-04-16	2016-02-17	三菱電機株式会社	内燃機関のシリンダ吸入空気量推定装置および推定方法
WO2016145102A1 (en)	2015-03-10	2016-09-15	Aduro Biotech, Inc.	Compositions and methods for activating "stimulator of interferon gene" -dependent signalling
EP3507367A4 (en)	2016-07-05	2020-03-25	Aduro BioTech, Inc.	CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
UY37695A (es)	2017-04-28	2018-11-30	Novartis Ag	Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
CN111868232B (zh)	2017-11-22	2024-05-28	Hdl治疗公司	用于对血浆处理*的流体回路进行灌注的*和方法
WO2019133358A2 (en)	2017-12-28	2019-07-04	Hdl Therapeutics, Inc.	Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
WO2019143955A1 (en)	2018-01-22	2019-07-25	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Broadly protective inactivated influenza virus vaccine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617457A1 (de) *	1966-12-16	1972-04-20	Erba Carlo Spa	Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte
US4036952A (en) *	1973-02-24	1977-07-19	Bayer Aktiengesellschaft	Ethyleneimine inactivated microorganisms
DE2321951C2 (de) *	1973-05-02	1975-05-07	Behringwerke Ag, 3550 Marburg	Verfahren zur Herstellung einer Diphtherie-Vaccine
US4086134A (en) *	1973-09-18	1978-04-25	University Of Glasgow	Method for preparation of vaccine against feline leukemia
GB1503388A (en) *	1975-07-01	1978-03-08	Inverni Della Beffa Spa	Pharmaceutically active complexes and pharmaceutical compositions containing them
US4452734A (en) *	1980-02-11	1984-06-05	Merck & Co., Inc.	Herpes subunit vaccine
US4481189A (en) *	1982-04-14	1984-11-06	New York Blood Center Inc.	Process for preparing sterilized plasma and plasma derivatives
US4645666A (en) *	1982-06-08	1987-02-24	The Regents Of The University Of California	Vaccine for bluetongue disease employing platinum compounds
US4530831A (en) *	1982-11-02	1985-07-23	Akzo N.V.	Infectious Bursal Disease vaccine
US4806350A (en) *	1986-04-18	1989-02-21	Norden Laboratories, Inc.	Vaccine formulation
EP0250128A3 (en) *	1986-06-18	1988-06-08	American Registry of Pathology	Novel virus isolated from patients with aids
DE3707987A1 (de) *	1987-03-12	1988-09-22	Behringwerke Ag	Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole
GB8906794D0 (en) *	1989-03-23	1989-05-10	Carroll Noel	Preparation of vaccines

1991
- 1991-05-17 GB GB919110808A patent/GB9110808D0/en active Pending
1992
- 1992-05-15 CA CA002068817A patent/CA2068817A1/en not_active Abandoned
- 1992-05-15 ES ES92304422T patent/ES2127203T3/es not_active Expired - Lifetime
- 1992-05-15 DE DE69227400T patent/DE69227400T2/de not_active Expired - Fee Related
- 1992-05-15 AU AU16340/92A patent/AU652447B2/en not_active Ceased
- 1992-05-15 IN IN294MA1992 patent/IN174080B/en unknown
- 1992-05-15 SG SG1996004956A patent/SG49763A1/en unknown
- 1992-05-15 BR BR929201848A patent/BR9201848A/pt not_active Application Discontinuation
- 1992-05-15 AT AT92304422T patent/ATE172642T1/de not_active IP Right Cessation
- 1992-05-15 EP EP92304422A patent/EP0514199B1/en not_active Expired - Lifetime
- 1992-05-18 NZ NZ24278092A patent/NZ242780A/en not_active IP Right Cessation
- 1992-05-18 JP JP4168187A patent/JPH05328967A/ja active Pending
- 1992-05-18 ZA ZA923607A patent/ZA923607B/xx unknown
- 1992-05-18 KR KR1019920008346A patent/KR0149182B1/ko not_active IP Right Cessation
- 1992-07-01 IE IE155692A patent/IE921556A1/en not_active IP Right Cessation
1996
- 1996-10-11 US US08/729,135 patent/US5698432A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0514199A3 (en)	1993-11-10
EP0514199A2 (en)	1992-11-19
AU652447B2 (en)	1994-08-25
DE69227400T2 (de)	1999-07-01
BR9201848A (pt)	1993-01-05
IN174080B (pt)	1994-09-10
ES2127203T3 (es)	1999-04-16
CA2068817A1 (en)	1992-11-18
ATE172642T1 (de)	1998-11-15
NZ242780A (en)	1994-07-26
JPH05328967A (ja)	1993-12-14
AU1634092A (en)	1992-12-17
SG49763A1 (en)	1998-06-15
IE921556A1 (en)	1992-11-18
EP0514199B1 (en)	1998-10-28
DE69227400D1 (de)	1998-12-03
KR920021162A (ko)	1992-12-18
KR0149182B1 (ko)	1998-10-15
GB9110808D0 (en)	1991-07-10
US5698432A (en)	1997-12-16

Publication	Publication Date	Title
EP0514199A3 (en)	1993-11-10	Vaccines and methods for their production
DE69434820D1 (de)	2006-09-21	Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
DE69737886D1 (de)	2007-08-16	Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
PT97754A (pt)	1992-04-30	Processo para a preparacao de composicoes farmaceuticas contendo pelo menos um agente inibidor da poli-(adp-ribose)-polimerase nomeadamente, uma amida aromatica, para o tratamento de infeccoes provocadas por virus
PL325338A1 (en)	1998-07-20	Methods of and compositions for selectivel;y modifying nucleic acids
ATE257175T1 (de)	2004-01-15	Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
PT92931A (pt)	1990-07-31	Metodo para tratar uma celula hospedeira ex-vivo para desordens hiperproliferativas ou infeccoes e respectiva construcao poli-nucleotidica
NO20001768L (no)	2000-06-02	Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
ATE358732T1 (de)	2007-04-15	Anti-virale vektoren
DE3684255D1 (de)	1992-04-16	Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung.
EP0507179A3 (en)	1993-04-07	Equine herpes viruses (ehv) containing foreign dna, process for their preparation and their use as vaccines
GR3034278T3 (en)	2000-12-29	Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification.
ATE179428T1 (de)	1999-05-15	Verfahren zur herstellung von hepatitis antigenen und impfstoffen
ES2062990T3 (es)	1995-01-01	Vacunas, que contienen la proteina f del virus del sida.
WO1993025707A3 (es)	1994-02-17	Procedimientos de amplificacion de genoma y mezclas de oligonucleotidos iniciadores para la deteccion y la identificacion de secuencias genomicas relacionadas
ES2367245T8 (es)	2011-12-09	Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
TH13476EX (th)	1993-12-15	วัคซีนและวิธีสำหรับการผลิต
DE69203192D1 (de)	1995-08-03	Verfahren zur Herstellung von N-Ethylhydroxylamin-Hydrochlorid.
FI893346A0 (fi)	1989-07-10	Icke-reverterande rna-virus.
HU9802975D0 (en)	1999-02-01	Recombinant avipox viruses, the culture of cells infected by these viruses, vaccines for poultry, transfer sequences for production of viruses and plas mids containing of these sequences and process for producing thereof and use of viruses as vectors
FI98466B (fi)	1997-03-14	FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi